Başlık için Bildiri Koleksiyonu listeleme
Toplam kayıt 516, listelenen: 221-240
-
Herpes ensefaliti sonrası gelişen zihin gezinmesi: Bir olgu sunumu
(Türkiye Sinir ve Ruh Sağlığı Derneği, 2021)Ensefalit beyin dokusunun enflamasyonu olarak tanımlanan bir tablodur. Ensefalitin alt tiplerinden biri olan herpes simpleks virüsü ensefalitinde beyinde frontal ve mezial temporal bölgelerin tutulumu karakteristiktir. ... -
High ferritin levels in fever of unknown origin: Possible first sign of hemophagocytosis in bmt patients?
(Ferrata Storti Foundation, 2016)... -
HLA-A allele mismatch (7/8 or 9/10) is the second best option after 8/8 or 10/10 matched unrelated donors: An analysis on results from Turkish centers
(Nature Publishing Group, 2015)Introduction: Hematopoietic stem cell transplantation (HSCT) from an unrelated donor has been established as an effective treatment option for patients with hematological diseases who lack a human leukocyte antigen ... -
Hodgkin lymphoma single centre experience: Akdeniz University paediatric haematology oncology
(Wiley-Blackwell, 2016)… -
Home mechanical ventilation in children: The experience of pediatric pulmonology divisions in Istanbul
(European Respiratory Society Journals Ltd, 2022)... -
How to decrease spine dose in patients who underwent sterotactic spine radiosurgery?
(Wiley, 2014)Purpose: Stereotactic radiosurgery for spine metastases involves irradiation using a single high dose fraction. The purpose of this study was to dosimetrically compare stereotactic spine radiosurgery(SRS) plans using a ... -
Hyperthermic intraperitoneal chemotherapy after secondary cytoreduction in epithelial ovarian cancer: A single-center experience
(Lippincott Williams, 2016)... -
Ibrutinib as a promising treatment for pulmonary complications due to refractory chronic graft versus host disease
(Elsevier Science Inc, 2020)Introduction: Despite major improvements in allogeneic hematopoetic stem cell transplantation form matched related/ unrelated donor over last decades, chronic graft-versus-host disease (cGVHD) is still the leading cause ... -
Idarubicin versus daunorubicin versus mitoxantrone for induction chemotherapy in acute myeloid leukemia: Patient registration study of Turkish society of hematologyacute myeloid leukemia working group
(American Society of Hematology, 2023)Introduction: Standard induction chemotherapy in newly diagnosed acute myeloid leukemia (AML) includes a combination of standard-dose cytarabine and an anthracycline (idarubicin [IDA], daunorubicin [DNR], or mitoxantrone ... -
Immunosuppressive treatment results in patients with primary iga nephropathy in Türkiye: A nationwide study
(Oxford University Press, 2023)...